Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer
Clinical trial NCT00284817 · COMPLETED
Trial details
- NCT number
- NCT00284817
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-07-01
- Primary completion
- 2005-01-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.